Liverpool HIV iChart is a medical reference tool for healthcare professionals and patients that provides a traffic-light system for identifying drug-drug interactions in HIV therapy.
The App DNA
What makes this app unique?
The app removes the need for constant connectivity when checking for medication contraindications, which is a critical safety requirement for patients managing complex, multi-drug regimens.
For Healthcare professionals and patients managing HIV therapy and co-existing conditions.
What does it look like?
Key features
Categorizes drug-drug interactions into red, amber, yellow, and green recommendations for clinical decision support.
Downloads full interaction data to the device for use without an active internet connection.
How much does it cost?
The application operates as a non-monetized public health resource supported by academic and industry sponsors.
Velocity
Dormant developmentopaqueShow more...
Liverpool HIV iChart has been inactive for over a year, with the last update recorded 404 days ago. The development history shows only minor bug fixes and flow adjustments, indicating a lack of new feature development or ongoing maintenance. Given the significant period of inactivity, the app is classified as a zombie project.
Who built it?
Liverpool Drug Interactions
5 apps tracked · Medical
Liverpool HIV iChart
Liverpool HEP iChart
Cancer iChart
COVID-19 iChartUser Sentiment
What do users think recently?
Recent user voice shows a frustrated sentiment. Users appreciate the comprehensive drug interaction database provides essential safety information for patients and their caregivers and mobile accessibility allows users to check medication safety while shopping or away from home.
How are ratings & reviews evolving?
What users say, by theme
- The comprehensive drug interaction database provides essential safety information for patients and their caregivers
- Mobile accessibility allows users to check medication safety while shopping or away from home
- Persistent update loops and database synchronization errors prevent users from accessing critical medical information
25 of 25 recent reviews analyzed · moderate confidence · Frustrated overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Liverpool HIV iChart
How's the Medical market?
Liverpool HIV iChart operates as a specialized medical utility with a 5-star rating on iOS, though it lacks recent development activity to maintain its standing in the medical category.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Liverpool HIV iChart
Where is it heading?
Users report: The medical reference market is consolidating around tools that offer frequent, automated data updates. Liverpool HIV iChart's current maintenance-mode status leaves it exposed to data obsolescence, which will likely drive users to more active alternatives if the update-loop failures are not resolved immediately.
- The 13-month release gap prevents the integration of new clinical data, which undermines the app's primary value as a reliable medical reference.
- Persistent update-loop failures prevent users from accessing the database, which directly causes the current negative sentiment trend among the user base.
The SWOT
- Offline-first database removes connectivity dependency for critical clinical decisions
- Adding a bookmarking function for frequently checked medications would improve user workflow
Next best moves
Rebuild database synchronization logic because update loops are the top-reported blocker → restore core utility
+ 1 more prioritized moveThe counter-intuitive read
The app's primary risk is not feature parity with rivals…
Read the full takeSince the last report: The application has seen no functional changes or feature updates, remaining in a zombie state for 13 months. The primary shift is a more critical framing of the development silence as a direct threat to clinical data accuracy.
Bottom line
Liverpool HIV iChart provides essential safety data, but the current technical instability and long release silence threaten its utility as a reliable clinical tool. Addressing the update-loop failures is the priority to restore the core value proposition for patients and providers.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated